vs
Maplebear Inc.（CART）とEncompass Health Corp（EHC）の財務データ比較。上の社名をクリックして会社を切り替えられます
Encompass Health Corpの直近四半期売上が大きい（$1.5B vs $992.0M、Maplebear Inc.の約1.6倍）。Encompass Health Corpの純利益率が高く（9.5% vs 8.2%、差は1.3%）。Maplebear Inc.の前年同期比売上増加率が高い（12.3% vs 9.9%）。Maplebear Inc.の直近四半期フリーキャッシュフローが多い（$171.0M vs $116.7M）。過去8四半期でMaplebear Inc.の売上複合成長率が高い（10.0% vs 8.3%）
Maplebear Inc.は「Instacart」のブランド名で事業を展開し、米国サンフランシスコに本社を置く小売メディア・配送企業です。米国とカナダで食料品の配送・店頭受取サービスを提供し、ユーザーは公式サイトやモバイルアプリから提携店舗の食料品や、法的に認められた地域ではアルコール飲料を注文でき、専任ショッパーが商品の選別、梱包、配送を担当します。
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
CART vs EHC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $992.0M | $1.5B |
| 純利益 | $81.0M | $146.1M |
| 粗利率 | 72.3% | — |
| 営業利益率 | 9.9% | 16.7% |
| 純利益率 | 8.2% | 9.5% |
| 売上前年比 | 12.3% | 9.9% |
| 純利益前年比 | -45.3% | 20.8% |
| EPS（希薄化後） | $0.31 | $1.43 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $992.0M | $1.5B | ||
| Q3 25 | $939.0M | $1.5B | ||
| Q2 25 | $914.0M | $1.5B | ||
| Q1 25 | $897.0M | $1.5B | ||
| Q4 24 | $883.0M | $1.4B | ||
| Q3 24 | $852.0M | $1.4B | ||
| Q2 24 | $823.0M | $1.3B | ||
| Q1 24 | $820.0M | $1.3B |
| Q4 25 | $81.0M | $146.1M | ||
| Q3 25 | $144.0M | $126.5M | ||
| Q2 25 | $116.0M | $142.1M | ||
| Q1 25 | $106.0M | $151.5M | ||
| Q4 24 | $148.0M | $120.9M | ||
| Q3 24 | $118.0M | $108.2M | ||
| Q2 24 | $61.0M | $114.1M | ||
| Q1 24 | $130.0M | $112.5M |
| Q4 25 | 72.3% | — | ||
| Q3 25 | 73.7% | — | ||
| Q2 25 | 74.2% | — | ||
| Q1 25 | 74.8% | — | ||
| Q4 24 | 75.2% | — | ||
| Q3 24 | 75.2% | — | ||
| Q2 24 | 75.7% | — | ||
| Q1 24 | 74.9% | — |
| Q4 25 | 9.9% | 16.7% | ||
| Q3 25 | 17.7% | 14.9% | ||
| Q2 25 | 13.6% | 16.2% | ||
| Q1 25 | 12.3% | 16.4% | ||
| Q4 24 | 17.6% | 14.3% | ||
| Q3 24 | 16.2% | 13.6% | ||
| Q2 24 | 6.3% | 14.3% | ||
| Q1 24 | 17.6% | 13.6% |
| Q4 25 | 8.2% | 9.5% | ||
| Q3 25 | 15.3% | 8.6% | ||
| Q2 25 | 12.7% | 9.7% | ||
| Q1 25 | 11.8% | 10.4% | ||
| Q4 24 | 16.8% | 8.6% | ||
| Q3 24 | 13.8% | 8.0% | ||
| Q2 24 | 7.4% | 8.8% | ||
| Q1 24 | 15.9% | 8.5% |
| Q4 25 | $0.31 | $1.43 | ||
| Q3 25 | $0.51 | $1.24 | ||
| Q2 25 | $0.41 | $1.39 | ||
| Q1 25 | $0.37 | $1.48 | ||
| Q4 24 | $0.53 | $1.18 | ||
| Q3 24 | $0.42 | $1.06 | ||
| Q2 24 | $0.20 | $1.12 | ||
| Q1 24 | $0.43 | $1.10 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $687.0M | $72.2M |
| 総負債低いほど良い | — | $2.4B |
| 株主資本純資産 | $2.5B | $2.4B |
| 総資産 | $3.7B | $7.1B |
| 負債/資本比率低いほどレバレッジが低い | — | 1.00× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $687.0M | $72.2M | ||
| Q3 25 | $1.7B | $48.7M | ||
| Q2 25 | $1.6B | $99.1M | ||
| Q1 25 | $1.6B | $95.8M | ||
| Q4 24 | $1.4B | $85.4M | ||
| Q3 24 | $1.3B | $147.8M | ||
| Q2 24 | $1.4B | $154.4M | ||
| Q1 24 | $1.5B | $134.4M |
| Q4 25 | — | $2.4B | ||
| Q3 25 | — | $2.4B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.3B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $2.3B | ||
| Q2 24 | — | $2.7B | ||
| Q1 24 | — | $2.7B |
| Q4 25 | $2.5B | $2.4B | ||
| Q3 25 | $3.5B | $2.4B | ||
| Q2 25 | $3.3B | $2.3B | ||
| Q1 25 | $3.2B | $2.2B | ||
| Q4 24 | $3.1B | $2.1B | ||
| Q3 24 | $2.9B | $2.0B | ||
| Q2 24 | $3.0B | $1.8B | ||
| Q1 24 | $3.1B | $1.7B |
| Q4 25 | $3.7B | $7.1B | ||
| Q3 25 | $4.5B | $6.9B | ||
| Q2 25 | $4.4B | $6.8B | ||
| Q1 25 | $4.3B | $6.6B | ||
| Q4 24 | $4.1B | $6.5B | ||
| Q3 24 | $3.9B | $6.5B | ||
| Q2 24 | $4.0B | $6.4B | ||
| Q1 24 | $4.1B | $6.2B |
| Q4 25 | — | 1.00× | ||
| Q3 25 | — | 1.01× | ||
| Q2 25 | — | 1.02× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | — | 1.14× | ||
| Q3 24 | — | 1.20× | ||
| Q2 24 | — | 1.46× | ||
| Q1 24 | — | 1.54× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $183.0M | $346.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $171.0M | $116.7M |
| FCFマージンFCF / 売上 | 17.2% | 7.6% |
| 設備投資強度設備投資 / 売上 | 1.2% | 14.8% |
| キャッシュ転換率営業CF / 純利益 | 2.26× | 2.37× |
| 直近12ヶ月FCF直近4四半期 | $910.0M | $439.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $183.0M | $346.0M | ||
| Q3 25 | $287.0M | $270.8M | ||
| Q2 25 | $203.0M | $270.2M | ||
| Q1 25 | $298.0M | $288.6M | ||
| Q4 24 | $153.0M | $278.8M | ||
| Q3 24 | $185.0M | $267.8M | ||
| Q2 24 | $244.0M | $217.4M | ||
| Q1 24 | $105.0M | $238.8M |
| Q4 25 | $171.0M | $116.7M | ||
| Q3 25 | $272.0M | $83.7M | ||
| Q2 25 | $187.0M | $113.3M | ||
| Q1 25 | $280.0M | $125.5M | ||
| Q4 24 | $141.0M | $80.1M | ||
| Q3 24 | $171.0M | $120.3M | ||
| Q2 24 | $220.0M | $60.5M | ||
| Q1 24 | $91.0M | $99.4M |
| Q4 25 | 17.2% | 7.6% | ||
| Q3 25 | 29.0% | 5.7% | ||
| Q2 25 | 20.5% | 7.8% | ||
| Q1 25 | 31.2% | 8.6% | ||
| Q4 24 | 16.0% | 5.7% | ||
| Q3 24 | 20.1% | 8.9% | ||
| Q2 24 | 26.7% | 4.6% | ||
| Q1 24 | 11.1% | 7.6% |
| Q4 25 | 1.2% | 14.8% | ||
| Q3 25 | 1.6% | 12.7% | ||
| Q2 25 | 1.8% | 10.8% | ||
| Q1 25 | 2.0% | 11.2% | ||
| Q4 24 | 1.4% | 14.1% | ||
| Q3 24 | 1.6% | 10.9% | ||
| Q2 24 | 2.9% | 12.1% | ||
| Q1 24 | 1.7% | 10.6% |
| Q4 25 | 2.26× | 2.37× | ||
| Q3 25 | 1.99× | 2.14× | ||
| Q2 25 | 1.75× | 1.90× | ||
| Q1 25 | 2.81× | 1.90× | ||
| Q4 24 | 1.03× | 2.31× | ||
| Q3 24 | 1.57× | 2.48× | ||
| Q2 24 | 4.00× | 1.91× | ||
| Q1 24 | 0.81× | 2.12× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CART
| Transaction | $698.0M | 70% |
| Advertising And Other | $294.0M | 30% |
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
